A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

A Richmond man wants you to know how nursing caregivers made a difference in his wife's treatment for Alzheimer's.

HEALTH MINUTE (CNN) - A new report shows that many people believe keeping their brain healthy is important, but they’re not ...

Why do memories fade in Alzheimer's disease—and can they be restored? University of California, Irvine researchers have ...

A rare group of adults over 80, known as SuperAgers, are rewriting what we thought was possible for the aging brain. With memory abilities comparable to people decades younger, their brains either ...

Scientists reprogram brain cells to remove Alzheimer’s plaques with a single injection, showing a new approach to long-term ...

Researchers at LMU have developed a human cell model that replicates key mechanisms of neurodegenerative diseases—with ...

Vitamin D in midlife is linked to lower Alzheimer’s-related tau buildup years later, offering new clues about early brain ...

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

The overall cost of Alzheimer’s care is expected to rise to over $400 billion this year, according to a new national report ...

Kristen Cusato from the Alzheimer's Association Northeast region breaks down the latest statistics; 7.4 million people in the ...